HCPCS Level II
J9179
Injection, eribulin mesylate, 0.1 mg
Codes near J9179
These sit next to J9179 in the CMS Level II file. All J codes
- J9174Injection, docetaxel (beizray), 1 mg
- J9175Injection, elliotts' b solution, 1 ml
- J9176Injection, elotuzumab, 1 mg
- J9177Injection, enfortumab vedotin-ejfv, 0.25 mg
- J9178Injection, epirubicin hcl, 2 mg
- J9181Injection, etoposide, 10 mg
- J9183Gemcitabine intravesical system, 225 mg
- J9184Injection, gemcitabine hydrochloride (avyxa), 200 mg
- J9185Injection, fludarabine phosphate, 50 mg
- J9186Injection, etoposide (avyxa), 1 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00143-9167-01 | Eribulin Mesylate | Hikma Pharmaceuticals USA Inc. | 10 |
| 00781-3391-94 | Eribulin Mesylate | Sandoz Inc. | 10 |
| 10019-0080-01 | Eribulin Mesylate | Baxter Healthcare Corporation | 10 |
| 39822-2080-01 | Eribulin Mesylate | XGen Pharmaceuticals DJB, Inc. | 10 |
| 43598-0125-11 | Eribulin Mesylate | Dr. Reddy's Laboratories Inc. | 10 |
| 60505-6289-00 | Eribulin Mesylate | Apotex Corp | 10 |
| 62856-0389-01 | Halaven | Eisai Inc. | 10 |
| 68001-0656-41 | Eribulin Mesylate | BluePoint Laboratories | 10 |
| 68462-0770-20 | Eribulin Mesylate | Glenmark Pharmaceuticals Inc., USA | 10 |
| 72603-0368-01 | Eribulin Mesylate | Northstar RxLLC | 10 |
| 81298-3890-01 | Eribulin Mesylate | Long Grove Pharmaceuticals, LLC | 10 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.